Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.
Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern.
Neuromyelitis optica: Aquaporin-4 based pathogenesis mechanisms and new therapies.
Remyelination Therapy for Multiple Sclerosis.
Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma.
Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: A pilot study.
Sulfatides in extracellular vesicles isolated from plasma of multiple sclerosis patients.
Viruses and Multiple Sclerosis.
The month of birth effect in multiple sclerosis: systematic review, meta-analysis and effect of latitude.
Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin.
The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS).
Utilization of brain MRI with focus on cerebral lesions and atrophy to better characterize MS phenotypes.
Effect of stress on brain inflammation and multiple sclerosis.
Familial comorbidity of bipolar disorder and multiple sclerosis: Genetic susceptibility, coexistence or causal relationship?
Mapi Pharma granted United States patent covering the process for the preparation of fingolimod for multiple sclerosis
Going Against the Tide - How Encephalitogenic T Cells Breach the Blood-Brain Barrier.
Association Between MTHFR Genetic Variants and Multiple Sclerosis in a Southern Iranian Population.
Ready or not: planning for health declines in couples with advanced multiple sclerosis.
Fine Mapping and Functional Analysis of the Multiple Sclerosis Risk Gene CD6.
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation.
Contribution of MicroRNAs to autoimmune diseases.
A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis.
Neuropathologic correlates of magnetic resonance imaging in multiple sclerosis.
B-cell enrichment and epstein-barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis.
[How to use Japanese guidelines for the treatment of multiple sclerosis].
Pages
« first
‹ previous
…
213
214
215
216
217
218
219
220
221
…
next ›
last »